Expert perspectives on the use of safinamide for Parkinson’s disease in Portugal: insights from a Portuguese Delphi Consensus
Aim: Safinamide is an approved medication for managing motor fluctuations in Parkinson’s disease (PD). However, limited data exist regarding its application in clinical practice in Portugal and the perspectives of Portuguese neurologists on its use. To address this, a group of Portuguese specialis...
Saved in:
| Main Authors: | Ana Margarida Rodrigues, Cristina Costa, Miguel Gago, Miguel Grunho, Leonor Correia Guedes, Ana Morgadinho, Maria Jose Rosas, Rita Simoes, Ana Graca Velon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Becaris Publishing Limited
2025-01-01
|
| Series: | Journal of Comparative Effectiveness Research |
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-Term Real-World Experience with Safinamide in Patients with Parkinson’s Disease
by: Anna Planas-Ballvé, et al.
Published: (2024-12-01) -
Use of safinamide for treatment of Parkinson disease: real-world data from Spain
by: María Isabel Morales Casado, et al.
Published: (2025-07-01) -
Effect of Safinamide on Non-Motor Symptoms and Quality of Life in Parkinson’s Disease Patients According to Sex, Age, Disease Duration and Levodopa Equivalent Daily Dose
by: Ángela Solleiro Vidal, et al.
Published: (2025-06-01) -
Is gut microbiota associated with Parkinson’s disease?
by: A. V. Tyakht, et al.
Published: (2017-01-01) -
Depression in Parkinson’s Disease – Profile and Assessment
by: Desislava Marinova, et al.
Published: (2023-12-01)